Are the Real World Patients with Advanced Non-Small Cell Lung Cancer Represented in Phase III Immunotherapy Trials?
J. Cé Coelho, T. Rebelato, A. Gelatti, R. D’Avila, G. Geib, P. Rubini Liedke,R. Peres Pereira, G. Werutsky, S. Jobim De Azevedo.
18th World Conference on Lung Cancer IASLC
Full link: https://www.jto.org/article/S1556-0864(17)31452-1/fulltext